SpectraCell Enters Into National Contract With Aetna
HOUSTON, Jan. 6 /PRNewswire/ -- SpectraCell Laboratories announced today that it has agreed with Aetna Health, one of the nation's largest health insurers, to become a contracted in-network provider. The contract provides coverage by Aetna of SpectraCell's micronutrient testing, as well as other advanced tests offered by the company.
Aetna is just one of a growing number of major insurance carriers that recognize the importance of nutrition in health and disease. They acknowledge SpectraCell's micronutrient testing as a valuable piece of the healthcare puzzle, changing the current paradigm of disease-care to true wellness-care and prevention.
"Much of the cutting edge technology in health care is emerging in the field of diagnostics. SpectraCell's micronutrient testing, originally developed at the University of Texas, is a prime example of advanced clinical tools," says Rusty Preece, VP and Chief Financial Officer of SpectraCell. "Insurers see the value in identification and targeted correction of patients' specific vitamin and mineral deficiencies, which have a major impact on underlying disease processes."
Even during the worst recession in decades, SpectraCell's client base expanded very aggressively in 2009. This is due largely to the fact that when physicians see how their patients' symptoms are resolved once they detect and correct (often multiple) micronutrient deficiencies, they recommend it to other physicians and order it on more and more patients.
Aetna covers over 19 million individuals in all 50 states. Its networks include almost one million health care professionals, over 500,000 of which are primary care physicians. SpectraCell serves over 3,500 physician clients nationally, spread across 42 states.
About SpectraCell Laboratories – SpectraCell is a CLIA accredited laboratory that services healthcare providers nationwide by providing advanced diagnostics, including comprehensive micronutrient testing and the Lipoprotein Particle Profile™ (LPP ™).
SpectraCell's micronutrienttesting provides an innovative analysis of a patient's nutritional status. Unlike traditional serum, hair and urine tests, SpectraCell's testsmeasure how an individual's white blood cells function in specific nutritional environments. Consequently, the test results take into account individual variations in metabolism, absorption rates, age, genetics, prescription drug usage and other factors. Over 30 vitamins, minerals, amino acids and antioxidants can be evaluated.
SpectraCell's Lipoprotein Particle Profile™ is the most advanced lipoprotein testing available. Unlike traditional cholesterol tests, SpectraCell's LPP™ directly measures both the size (density) and number of several classes of lipoprotein particles, providing an accurate assessment of cardiovascular risk.
http://www.spectracell.com
SOURCE SpectraCell Laboratories



N.Y. Regulator Settles Unlicensed Adjusters Dispute With Chartis
Advisor News
- The hidden flaw in insurance AI adoption for advisors and carriers
- Rising healthcare costs impact 401(k) accounts
- What advisors think about pooled employer plans, alternative investments
- AI, stablecoins and private market expansion may reshape financial services by 2030
- Cheers to summer, and planning for what comes next
More Advisor NewsAnnuity News
- MetLife Inc. (NYSE: MET) Climbs to New 52-Week High
- The Standard and Pacific Guardian Life Announce Entry into Agreement to Transition Individual Annuities Business
- AuguStar Retirement launches StarStream Variable Annuity
- Prismic Life Announces Completion of Oversubscribed Capital Raise
- Guaranteed income streams help preserve assets later in retirement
More Annuity NewsHealth/Employee Benefits News
- Reduced health insurance payments for hospital births had a bigger impact on sterilization rates than correcting an injustice
- Reports Summarize Pulpotomy Findings from National Health Insurance Service Ilsan Hospital (Trends and Outcomes of Vital Pulp Therapy in Korea: A Nationwide Retrospective Cohort Study): Surgery – Pulpotomy
- Reports on Managed Care Findings from Harvey L. Neiman Health Policy Institute Provide New Insights (Self-Interpretation of Imaging Studies by Ordering Providers: Frequency and Associated Provider and Practice Characteristics): Managed Care
- Investigators at Harvard Medical School Detail Findings in Managed Care (What Happens When Coverage Is Cut? Looking Backward and Forward From the One Big Beautiful Bill): Managed Care
- Researchers at Weill Cornell Medicine Cornell University Release New Data on Managed Care (Trends in prescription drug coverage restrictions in Medicare, Medicaid, and commercial insurance plans, 2011-2019): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- Shocking death of Kyle Busch renews debate over IUL plan
- WoodmenLife launches final expense life insurance offering
- The Standard and Pacific Guardian Life Announce Entry into Agreement to Transition Individual Annuities Business
- Symetra Wins 2026 Shorty Award for ‘Plan Well, Play Well’ Social Media Campaign with Sue Bird
- Rehabilitator: PHL Variable liquidation payouts could exceed guaranty caps
More Life Insurance News